Articles Vol. 63 No. chuyên đề 2-HN Y học Giới tính (2022) 18/11/2022

ENDOMETRIOSIS AND FEMALE SEXUAL DYSFUNCTION

Tran Thi Nhu Quynh1,2, Le Minh Tam3,4
1 Hue University Hospital
2 Bệnh viện Trường Đại học Y - Dược Huế
3 Hue University of Medicine and Pharmacy
4 Trường Đại học Y - Dược, Đại học Huế
Corresponding author: trtnquynh@bv.huemed-univ.edu.vn
DOI: 10.52163/yhc.v63i7.487
14 Views
0 Downloads
Keywords
Endometriosis, female sexual dysfunction.
Abstract

Introduction: Endometriosis is a common gynecological disease with painful symptoms
including: dysmenorrhea (60-80%), chronic pelvic pain (30-50%), infertility (30-40%) and
sexual pain (25-40%). Therefore, endometriosis can more or less affect the quality of a
woman’s sex life and sometimes is a direct cause of female sexual dysfunction.
Methods: Studies on endometriosis, the effects of the disease on female sexual function and
treatment methods were collected from PubMed database.
Results: Female sexual dysfunction, mainly sexual pain, is the most commonly described
symptom in cases of endometriosis. Meanwhile, therapies for the pain caused by endometriosis
are controversial about the effectiveness and duration of symptoms.
Discussions: The treatment of symptoms and complications caused by endometriosis
currently has not had a great consensus, showing the important role of clinical experts in
choosing the regimen for the goal of pain relief, reduce fatigue, improve work productivity
and improve quality of life, especially sexual function.
Conclusion: Endometriosis is a disease that affects all aspects of a woman’s life, including
sexual function.

References
[1]
Bulun SE, Yilmaz BD et al., Endometriosis. Google Scholar
[2]
Endocr. Rev. 2019;1:1048–1079. Google Scholar
[3]
Pessoa de Farias RM, Lima VF et al., Google Scholar
[4]
Clinical aspects and the quality of life among Google Scholar
[5]
women with endometriosis and infertility: Google Scholar
[6]
A cross-sectional study. BMC Womens Google Scholar
[7]
Health. 2020;12:124. Google Scholar
[8]
La Rosa VL, De FP, Quality of life in Google Scholar
[9]
women with endometriosis: A narrative Google Scholar
[10]
overview. Minerva Med. 2020;111:68–78. Google Scholar
[11]
Rush G, Misajon R, Examining subjective Google Scholar
[12]
wellbeing and health-related quality of life Google Scholar
[13]
in women with endometriosis. Health Care Google Scholar
[14]
Women Int. 2018;39:303–321. Google Scholar
[15]
Vercellini P, Are combined hormonal Google Scholar
[16]
contraceptives the neglected treatment Google Scholar
[17]
for symptomatic endometriosis? Fertil. Google Scholar
[18]
Steril. 2018;110:61–62. Google Scholar
[19]
Vercellini P, Facchin F, Management Google Scholar
[20]
of endometriosis: Toward value-based, Google Scholar
[21]
cost-effective, affordable care. J. Obstet. Google Scholar
[22]
Gynaecol. Can. 2018;40:726–749.e10. Google Scholar
[23]
Vercellini P, Donati A, A stepped-care Google Scholar
[24]
approach to symptomatic endometriosis Google Scholar
[25]
management: A participatory research Google Scholar
[26]
initiative. Fertil. Steril.2018;109:1086–1096. Google Scholar
[27]
Reis FM, Coutinho LM, Vannuccini S et Google Scholar
[28]
al., Progesterone receptor ligands for the Google Scholar
[29]
treatment of endometriosis: The mechanisms Google Scholar
[30]
behind therapeutic success and failure. Hum. Google Scholar
[31]
Reprod. Updat. 2020;26:565–585. Google Scholar
[32]
Surrey E, Taylor HS, Long-term outcomes Google Scholar
[33]
of elagolix in women with endometriosis: Google Scholar
[34]
Results from two extension studies. Obstet. Google Scholar
[35]
Gynecol. 2018;132:147–160. Google Scholar
[36]
Osuga Y, Seki Y, Tanimoto M et al., an oral Google Scholar
[37]
gonadotropin-releasing hormone receptor Google Scholar
[38]
antagonist, reduces endometriosis-associated Google Scholar
[39]
pain in a dose-response manner: A randomized, Google Scholar
[40]
double-blind, place-bo-controlled study. Fertil. Google Scholar
[41]
Steril. 2021;115:397–405. Google Scholar
[42]
Donnez J, Taylor HS, Treatment of endometriosis-associated pain with linzagolix, Google Scholar
[43]
an oral gonadotropin-releasing hormoneantagonist: A randomized clinical trial. Fertil. Google Scholar
[44]
Steril. 2020;114:44–55. Google Scholar
[45]
Pohl O, Marchand L, Bell D et al., Effects Google Scholar
[46]
of combined GnRH receptor antagonist Google Scholar
[47]
linzagolix and hormonal add-back therapy on Google Scholar
[48]
vaginal bleeding—Delayed add-back onset Google Scholar
[49]
does not improve bleeding pattern. Reprod. Google Scholar
[50]
Sci. 2020;27:988–995. Google Scholar
[51]
Taylor HS, Dun EC, Chwalisz K, Clinical Google Scholar
[52]
evaluation of the oral gonadotropinreleasing hormone-antagonist elagolix for Google Scholar
[53]
the management of endometriosis-associated Google Scholar
[54]
pain. Pain Manag. 2019;9:497–515. Google Scholar
[55]
Donnez O, Donnez J, Gonadotropinreleasing hormone antagonist (linzagolix): A Google Scholar
[56]
new therapy for uterine adenomyosis. Fertil. Google Scholar
[57]
Steril. 2020;114:640–645. Google Scholar
[58]
Barra F, Scala C, Ferrero S, Elagolix sodium Google Scholar
[59]
for the treatment of women with moderate to Google Scholar
[60]
severe endometriosis-associated pain. Drugs Google Scholar
[61]
Today. 2019;55:237–246.89 Google Scholar
[62]
Lamb YN, Elagolix: First global Google Scholar
[63]
approval. Drugs. 2018;78:1501–1508. Google Scholar
[64]
Archer DF, Soliman AM, Agarwal SK et al., Google Scholar
[65]
Elagolix in the treatment of endometriosis: Google Scholar
[66]
impact beyond pain symptoms. Ther Adv Google Scholar
[67]
Reprod Health. 2020;14:2633494120964517. Google Scholar
[68]
Published 2020 Dec 1. Google Scholar
[69]
As-Sanie S, Becker CM, Efficacy and Google Scholar
[70]
safety of relugolix combination therapy Google Scholar
[71]
in women with endometriosis-associated Google Scholar
[72]
pain: Phase 3 randomized, double-blind, Google Scholar
[73]
placebo-controlled study (spirit 2) Fertil. Google Scholar
[74]
Steril. 2020;114:e77. Google Scholar
[75]
Donnez J, Dolmans MM, Endometriosis Google Scholar
[76]
and Medical Therapy: From Progestogens Google Scholar
[77]
to Progesterone Resistance to GnRH Google Scholar
[78]
Antagonists: A Review. J Clin Med. Google Scholar
[79]
;10(5):1085. Published 2021 Mar 5. Google Scholar
[80]
Awad E, Ahmed HAH, Yousef A et al., Google Scholar
[81]
Efficacy of exercise on pelvic pain and Google Scholar
[82]
posture associated with endometriosis: Google Scholar
[83]
Within subject design. J. Phys. Ther. Google Scholar
[84]
Sci. 2017;29:2112–2115. Google Scholar
[85]
Leonardi M, Horne AW, Selfmanagement strategies to consider to Google Scholar
[86]
combat endometriosis symptoms during Google Scholar
[87]
the COVID-19 pandemic. Hum. Reprod. Google Scholar
[88]
Open. 2020;1:hoaa028. Google Scholar
[89]
Mińko A, Turoń-Skrzypińska A, Rył A et al., Google Scholar
[90]
Endometriosis-A Multifaceted Problem of a Google Scholar
[91]
Modern Woman. Int J Environ Res Public Google Scholar
[92]
Health. 2021;18(15):8177. Published 2021 Google Scholar
[93]
Aug 2. Google Scholar
[94]
Stanton AM, Handy AB, Meston CM, The Google Scholar
[95]
Effects of Exercise on Sexual Function in Google Scholar
[96]
Women. Sex. Med. Rev. 2018;6:548–557. Google Scholar